Lithium diagnostic assay may display falsely elevated results on Atellica CH analyzer
The Atellica CH Lithium_2 diagnostic assay may produce falsely elevated lithium readings on the Atellica CH 930 analyzer, potentially leading to incorrect medication dosage adjustments. No illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II medical device recall with potential to cause harm through inaccurate treatment decisions. No illnesses or injuries have been reported, and the hazard is described as potential rather than confirmed, which per the rubric qualifies this as High (3).
Plain-English summary
Siemens Healthcare Diagnostics has recalled the Atellica CH Lithium_2 (LITH_2) in vitro diagnostic assay (Material Number 11532401), which measures lithium levels in patient blood samples on the Atellica CH 930 analyzer.
The assay has a potential to produce falsely elevated lithium readings. In the worst case, this could result in erroneously elevated lithium patient results, which may lead healthcare providers to make inappropriate medication dosage adjustments. No illnesses or injuries have been reported in connection with this issue.
The recall affects 1,342 units distributed in the United States and 2,266 units distributed outside the United States. The affected lot numbers are: 110238 (expiring 10/18/22), 110302 (expiring 12/13/22), and 120017 (expiring 4/18/23). Healthcare facilities currently using this assay should verify their lot numbers against the recall information and contact Siemens directly for remediation guidance.
The recalled product
- Product
- Atellica CH Lithium_2 (LITH_2), Siemens Material Number 11532401. in vitro diagnostic assay
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Siemens Healthcare Diagnostics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc.
See all →- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · measurement error
See all →- HighPhilips Evolution Upgrade 1.5T MRI Stiffness Calculation Error
FDA (Devices) · 2026-05-06
- ModeratePhilips MR 7700 MRE Upgrade MRI Equipment Stiffness Value Error Risk
FDA (Devices) · 2026-05-06
- ModeratePhilips MR 7700 MR Elastography device stiffness value error recall
FDA (Devices) · 2026-05-06
- ModeratePhilips SmartPath to Ingenia Elition X MR Elastography Stiffness Value Errors
FDA (Devices) · 2026-05-06
- ModeratePhilips Achieva 1.5T MRI System MRE Protocol Parameter Error Recall
FDA (Devices) · 2026-05-06